Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial.
| Autor: | Breder, Ikaro, Cunha Breder, Jessica, Bonilha, Isabella, Munhoz, Daniel B., Medorima, Sheila T. Kimura, Oliveira, Daniela C., Carmo, Helison R. do, Moreira, Camila, Kontush, Anatol, Zimetti, Francesca, Zanotti, Ilaria, Carvalho, Luiz Sergio F., Nadruz, Wilson, Muscelli, Elza, Quinaglia, Thiago, Sposito, Andrei C. |
|---|---|
| Zdroj: | Therapeutic Advances in Chronic Disease; 9/1/2020, p1-11, 11p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|